 |
|
Microbiologic Determinants of Exacerbation in Chronic Obstructive Pulmonary Disease
Antoni Rosell, MD;
Eduard Monsó, MD;
Néstor Soler, MD;
Ferràn Torres, MD;
Joaquim Angrill, MD;
Gerdt Riise, MD;
Rafael Zalacaín, MD;
Josep Morera, MD;
Antoni Torres, MD
Arch Intern Med. 2005;165:891-897.
Background The culture of bronchial secretions from the lower airway has been reported to be positive for potentially pathogenic microorganisms (PPMs) in patients with stable chronic obstructive pulmonary disease (COPD), but the determinants and effects of this bacterial load in the airway are not established.
Methods To determine the bronchial microbial pattern in COPD and its relationship with exacerbation, we pooled analysis of crude data from studies that used protected specimen brush sampling, with age, sex, smoking, lung function, and microbiologic features of the lower airway as independent variables and exacerbation as the outcome, using logistic regression modeling.
Results Of 337 study participants, 70 were healthy, 181 had stable COPD, and 86 had exacerbated COPD. Differences in the microbial characteristics in the participating laboratories were not statistically significant. A cutoff point of 102 colony-forming units (CFU) per milliliter or greater for the identification of abnormal positive culture results for PPMs was defined using the 95th percentile in the pooled analysis of healthy individuals. Bronchial colonization of 102 CFU/mL or greater by PPMs was found in 53 patients with stable COPD (29%) and in 46 patients with exacerbated COPD (54%) (P<.001,  2 test), with a predominance of Haemophilus influenzae and Pseudomonas aeruginosa. Higher microbial loads were associated with exacerbation and showed a statistically significant dose-response relationship after adjustment for covariates (odds ratio, 3.62; 95% confidence interval, 1.47-8.90), but P aeruginosa persisted as a statistically significant risk factor after adjustment for microbial load (odds ratio, 11.12; 95% confidence interval, 1.17-105.82).
Conclusions One quarter of the patients with COPD are colonized by PPMs during their stable periods. Exacerbation is associated with the overgrowth of PPMs and with the appearance of P aeruginosa in the lower airway, which is associated with exacerbation symptoms independent of load.
Author Affiliations: Servei de Pneumologia, Hospital Germans Trias i Pujol, Badalona, Spain (Drs Rosell, Monsó, and Morera); Institut Clínic de Pneumologia i Cirurgia Toràcica, Hospital Clínic i Provincial, Barcelona, Spain (Drs Soler, Angrill, and A. Torres); Laboratori de Bioestadística i Epidemiologia, Hospital de Sant Pau, Barcelona (Dr F. Torres); Department of Pulmonary Medicine, Sahlqrenska University Hospital, Göteborg, Sweden (Dr Riise); and Servicio de Neumología, Hospital de Cruces, Cruces-Barakaldo, Vizcaya, Spain (Dr Zalacaín).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study
Garcia-Vidal et al.
Eur Respir J 2009;34:1072-1078.
ABSTRACT
| FULL TEXT
Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD
Miravitlles et al.
Eur Respir J 2009;34:1066-1071.
ABSTRACT
| FULL TEXT
Nontypeable Haemophilus influenzae Protein E Binds Vitronectin and Is Important for Serum Resistance
Hallstrom et al.
J. Immunol. 2009;183:2593-2601.
ABSTRACT
| FULL TEXT
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
Sethi and Murphy
NEJM 2008;359:2355-2365.
FULL TEXT
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases
Burgel and Nadel
Eur Respir J 2008;32:1068-1081.
ABSTRACT
| FULL TEXT
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease
Murphy et al.
Am. J. Respir. Crit. Care Med. 2008;177:853-860.
ABSTRACT
| FULL TEXT
Review: Surfactant protein D: A lung specific biomarker in COPD?
Sin et al.
Ther Adv Respir Dis 2008;2:65-74.
ABSTRACT
Inflammatory Profile of New Bacterial Strain Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi et al.
Am. J. Respir. Crit. Care Med. 2008;177:491-497.
ABSTRACT
| FULL TEXT
Diagnosis of Pathogens in Exacerbations of Chronic Obstructive Pulmonary Disease
Sykes et al.
Proc Am Thorac Soc 2007;4:642-646.
ABSTRACT
| FULL TEXT
Pathogen-directed Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Martinez
Proc Am Thorac Soc 2007;4:647-658.
ABSTRACT
| FULL TEXT
Airway Bacterial Concentrations and Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi et al.
Am. J. Respir. Crit. Care Med. 2007;176:356-361.
ABSTRACT
| FULL TEXT
Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease
Soler et al.
Thorax 2007;62:29-35.
ABSTRACT
| FULL TEXT
Chronic Obstructive Pulmonary Disease, Risk Factors, and Outcome Trials: Comparisons with Cardiovascular Disease
Ramsey and Hobbs
Proc Am Thorac Soc 2006;3:635-640.
ABSTRACT
| FULL TEXT
Conserved Nontypeable Haemophilus influenzae-Derived TLR2-Binding Lipopeptides Synergize with IFN-beta to Increase Cytokine Production by Resident Murine and Human Alveolar Macrophages
Punturieri et al.
J. Immunol. 2006;177:673-680.
ABSTRACT
| FULL TEXT
Update in chronic obstructive pulmonary disease 2005.
Fabbri et al.
Am. J. Respir. Crit. Care Med. 2006;173:1056-1065.
FULL TEXT
Airway Inflammation and Bronchial Bacterial Colonization in Chronic Obstructive Pulmonary Disease
Sethi et al.
Am. J. Respir. Crit. Care Med. 2006;173:991-998.
ABSTRACT
| FULL TEXT
Coinfection in Exacerbations of COPD: A New Frontier.
Sethi
Chest 2006;129:223-224.
FULL TEXT
|
